|
Review Article
Transdermal Spray in
Hormone Delivery
Evren Algın-Yapar1*
and Özge İnal2
1The Ministry of Health of
Turkey, Turkish Medicines and Medical Devices Agency,
Söğütözü Mahallesi, 2176. Sokak No. 5, 06520 Çankaya-Ankara,
2Department of Pharmaceutical Technology,
Faculty of Pharmacy, University of Ankara, 06100
Tandoğan- Ankara, Turkey
*For correspondence:
Email:
evren.yapar@yahoo.com,
algin@pharmacy.ankara.edu.tr;
Tel: +90 0532 382 56 86
Received: 23 July 2012
Revised accepted: 15
February 2014
Tropical Journal of
Pharmaceutical Research, March 2014;
13(3):
469-474
http://dx.doi.org/10.4314/tjpr.v13i3.23
Abstract
This review examines
advances in hormone delivery, particularly using
transdermal spray. Transdermal gels, emulsions, patches,
subcutaneous implants and sprays have been developed for
transdermal hormone therapy in recent years. Transdermal
sprays, in their general form of metered-dose
transdermal spray, possess major advantages such as
enhanced passive transdermal drug delivery with little
or no skin irritations, improved cosmetic acceptability,
dose flexibility, uniform distribution on the
application site and ease of manufacture, and have thus
assumed significant importance in hormone delivery.
Estradiol, nestrone, testosterone and hydrocortisone
aceponate are some of the drugs prepared as metered-dose
transdermal spray. Results from recent surveys indicate
that there is a market for the delivery system and
ongoing development of transdermal sprays for hormone
delivery.
Keywords:
Transdermal,
Delivery systems, Metered dose, Spray, Hormone |